WOLV
WOLV is a research blend of two peptides — BPC-157 (a 15–amino-acid gastric-derived peptide) and TB-500 (a 43–amino-acid synthetic analog of thymosin beta-4). It is studied in preclinical models of tissue and vascular biology.
Key research areas
- Tissue repair research
- Vascular & endothelial function
- Angiogenesis
- Cell migration & actin dynamics
- Inflammatory signaling
Mechanism overview
WOLV pairs the reported activities of its two components. In preclinical research, BPC-157 has been associated with the eNOS nitric-oxide pathway and VEGF-related blood-vessel formation. TB-500, derived from thymosin beta-4, binds G-actin monomers to influence cell migration and is associated with VEGF-driven angiogenesis and modulation of inflammatory mediators. Human evidence for both remains limited and largely preclinical.
Format and storage
Certificates of analysis
Certificates of analysis are listed per lot. None published yet.
Research use only
WOLV is supplied for laboratory research purposes only. It is not a drug, food, dietary supplement, or cosmetic, and must not be labeled, marketed, or used as any of these. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.
Purchasers are responsible for determining that their intended use complies with all applicable laws and regulations, and for ensuring that products are handled by qualified personnel under appropriate laboratory conditions.
Related products
Research use only
Apex Research supplies peptides and proteins for laboratory research. Products are not for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any disease.
By continuing, you confirm that:
- You are at least 21 years of age
- You are acquiring these products for laboratory research purposes only
- You will not administer these products to humans or animals
- You are responsible for compliance with all applicable laws and regulations in your jurisdiction